Jennifer H. Lofland, Ph.D.

2004 Johns Hopkins University, Baltimore, MD 
Public Health, Occupational Health and Safety, Health Care Management
"Jennifer Lofland"
Cross-listing: PHTree


Sign in to add mentor
Kevin D. Frick grad student 2004 Johns Hopkins
 (Access to health care and workplace absenteeism for individuals with migraine headache.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kandane-Rathnayake R, Louthrenoo W, Luo SF, et al. (2020) Ab0384 Medication Use In Systemic Lupus Erythematosus – Data From A Multicentre Cohort Study Annals of the Rheumatic Diseases. 79: 1492-1493
Kariburyo F, Xie L, Sah J, et al. (2019) Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States. Journal of Medical Economics. 1
Xie L, Kariburyo F, Sah J, et al. (2019) Fri0201 Real World Medication Use In Incident Systemic Lupus Erythematosus And Lupus Nephritis Patients Annals of the Rheumatic Diseases. 78: 779-780
Touma Z, Hoskin B, Atkinson C, et al. (2019) Ab0486 Lack Of Consistent Standard Of Care In Systemic Lupus Erythematosus Patients In Real World Annals of the Rheumatic Diseases. 78: 1706-1706
Costenbader K, Hoskin B, Atkinson C, et al. (2019) Fri0256 Assessing The Prevalence And Use Of Validated Systemic Lupus Erythematosus Disease Activity Metrics In Real World Practice Annals of the Rheumatic Diseases. 78: 807-808
Lin X, Lofland J, Zhang L, et al. (2018) P715 Opioid use in patients with inflammatory bowel disease Journal of Crohn's and Colitis. 12: S473-S473
Lin X, Lofland J, Zhang L, et al. (2018) Sa1811 - Opioid use in Patients with Inflammatory Bowel Disease Gastroenterology. 154: S-404
Lofland JH, Johnson PT, Ingham MP, et al. (2017) Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Preference and Adherence. 11: 947-958
Bolge SC, Eldridge HM, Lofland JH, et al. (2017) Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Patient Preference and Adherence. 11: 661-669
Tkacz J, Brady BL, Meyer R, et al. (2015) An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease. Journal of Managed Care & Specialty Pharmacy. 21: 1064-76
See more...